This report contains market size and forecasts of In-Vitro Colorectal Cancer Screening Tests in Global, including the following market information:
Global In-Vitro Colorectal Cancer Screening Tests Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global In-Vitro Colorectal Cancer Screening Tests market was valued at 1018.5 million in 2020 and is projected to reach US$ 1250.4 million by 2027, at a CAGR of 5.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In-Vitro Colorectal Cancer Screening Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In-Vitro Colorectal Cancer Screening Tests Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global In-Vitro Colorectal Cancer Screening Tests Market Segment Percentages, By Type, 2020 (%)
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
China In-Vitro Colorectal Cancer Screening Tests Market, By Application, 2016-2021, 2022-2027 ($ millions)
China In-Vitro Colorectal Cancer Screening Tests Market Segment Percentages, By Application, 2020 (%)
Hospital and Clinics
Ambulatory
Home Care
Global In-Vitro Colorectal Cancer Screening Tests Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global In-Vitro Colorectal Cancer Screening Tests Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total In-Vitro Colorectal Cancer Screening Tests Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total In-Vitro Colorectal Cancer Screening Tests Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 In-Vitro Colorectal Cancer Screening Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global In-Vitro Colorectal Cancer Screening Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global In-Vitro Colorectal Cancer Screening Tests Overall Market Size
2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size: 2021 VS 2027
2.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In-Vitro Colorectal Cancer Screening Tests Players in Global Market
3.2 Top Global In-Vitro Colorectal Cancer Screening Tests Companies Ranked by Revenue
3.3 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Companies
3.4 Top 3 and Top 5 In-Vitro Colorectal Cancer Screening Tests Companies in Global Market, by Revenue in 2020
3.5 Global Companies In-Vitro Colorectal Cancer Screening Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-Vitro Colorectal Cancer Screening Tests Players in Global Market
3.6.1 List of Global Tier 1 In-Vitro Colorectal Cancer Screening Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 In-Vitro Colorectal Cancer Screening Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global In-Vitro Colorectal Cancer Screening Tests Market Size Markets, 2021 & 2027
4.1.2 Biomarker Tests
4.1.3 Fecal Occult Blood Tests
4.1.4 CRC DNA Screening Tests
4.2 By Type - Global In-Vitro Colorectal Cancer Screening Tests Revenue & Forecasts
4.2.1 By Type - Global In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2021
4.2.2 By Type - Global In-Vitro Colorectal Cancer Screening Tests Revenue, 2022-2027
4.2.3 By Type - Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global In-Vitro Colorectal Cancer Screening Tests Market Size, 2021 & 2027
5.1.2 Hospital and Clinics
5.1.3 Ambulatory
5.1.4 Home Care
5.2 By Application - Global In-Vitro Colorectal Cancer Screening Tests Revenue & Forecasts
5.2.1 By Application - Global In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2021
5.2.2 By Application - Global In-Vitro Colorectal Cancer Screening Tests Revenue, 2022-2027
5.2.3 By Application - Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global In-Vitro Colorectal Cancer Screening Tests Market Size, 2021 & 2027
6.2 By Region - Global In-Vitro Colorectal Cancer Screening Tests Revenue & Forecasts
6.2.1 By Region - Global In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2021
6.2.2 By Region - Global In-Vitro Colorectal Cancer Screening Tests Revenue, 2022-2027
6.2.3 By Region - Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2027
6.3.2 US In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.3.3 Canada In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.3.4 Mexico In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2027
6.4.2 Germany In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.4.3 France In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.4.4 U.K. In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.4.5 Italy In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.4.6 Russia In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.4.7 Nordic Countries In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.4.8 Benelux In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2027
6.5.2 China In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.5.3 Japan In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.5.4 South Korea In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.5.5 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.5.6 India In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2027
6.6.2 Brazil In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.6.3 Argentina In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue, 2016-2027
6.7.2 Turkey In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.7.3 Israel In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.7.4 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
6.7.5 UAE In-Vitro Colorectal Cancer Screening Tests Market Size, 2016-2027
7 Players Profiles
7.1 Alere(Abbott)
7.1.1 Alere(Abbott) Corporate Summary
7.1.2 Alere(Abbott) Business Overview
7.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.1.5 Alere(Abbott) Key News
7.2 Beckman Coulter
7.2.1 Beckman Coulter Corporate Summary
7.2.2 Beckman Coulter Business Overview
7.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.2.5 Beckman Coulter Key News
7.3 Siemens Healthcare
7.3.1 Siemens Healthcare Corporate Summary
7.3.2 Siemens Healthcare Business Overview
7.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.3.5 Siemens Healthcare Key News
7.4 Eiken Chemical
7.4.1 Eiken Chemical Corporate Summary
7.4.2 Eiken Chemical Business Overview
7.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.4.5 Eiken Chemical Key News
7.5 Hitachi Chemical (Kyowa Medex)
7.5.1 Hitachi Chemical (Kyowa Medex) Corporate Summary
7.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
7.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.5.5 Hitachi Chemical (Kyowa Medex) Key News
7.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
7.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Corporate Summary
7.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
7.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Key News
7.7 Sysmex
7.7.1 Sysmex Corporate Summary
7.7.2 Sysmex Business Overview
7.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.4.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.7.5 Sysmex Key News
7.8 QIAGEN
7.8.1 QIAGEN Corporate Summary
7.8.2 QIAGEN Business Overview
7.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.8.5 QIAGEN Key News
7.9 R-Biopharm
7.9.1 R-Biopharm Corporate Summary
7.9.2 R-Biopharm Business Overview
7.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.9.5 R-Biopharm Key News
7.10 Immunostics
7.10.1 Immunostics Corporate Summary
7.10.2 Immunostics Business Overview
7.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
7.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue in Global (2016-2021)
7.10.5 Immunostics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. In-Vitro Colorectal Cancer Screening Tests Market Opportunities & Trends in Global Market
Table 2. In-Vitro Colorectal Cancer Screening Tests Market Drivers in Global Market
Table 3. In-Vitro Colorectal Cancer Screening Tests Market Restraints in Global Market
Table 4. Key Players of In-Vitro Colorectal Cancer Screening Tests in Global Market
Table 5. Top In-Vitro Colorectal Cancer Screening Tests Players in Global Market, Ranking by Revenue (2019)
Table 6. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Companies, 2016-2021
Table 8. Global Companies In-Vitro Colorectal Cancer Screening Tests Product Type
Table 9. List of Global Tier 1 In-Vitro Colorectal Cancer Screening Tests Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In-Vitro Colorectal Cancer Screening Tests Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type